.svg){kind=small}
Oct-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the state of Illinois, Remedi has shown noteworthy performance across several categories, particularly in Capsules and Tincture & Sublingual products. In the Capsules category, Remedi maintained a steady sixth-place ranking from July to September 2024, before improving to fifth place in October. This upward movement suggests a positive reception and growing consumer preference. Meanwhile, in the Tincture & Sublingual category, Remedi consistently held the fourth position throughout the months from July to October, indicating a stable market presence. In contrast, the brand's performance in Concentrates saw a slight fluctuation, moving from 21st place in July to 17th in October, hinting at a potential area for growth and increased focus.
In Massachusetts, Remedi experienced significant shifts, particularly in the Concentrates category. Starting from a 19th place ranking in July, the brand improved to 14th place by October, reflecting a positive trend and potentially increased market penetration. This improvement in ranking is accompanied by a notable increase in sales from August to October, suggesting that Remedi's strategies in Massachusetts are beginning to yield results. However, the absence of Remedi in the top 30 for other categories in Massachusetts implies that there are still opportunities for the brand to expand its footprint and diversify its offerings in this particular market.
Competitive Landscape
In the Illinois concentrates market, Remedi has shown a consistent presence, maintaining a rank within the top 20 from July to October 2024. Despite a slight dip in rank from 16th to 17th place in October, Remedi's sales have demonstrated resilience, increasing from August to October. This upward sales trend is notable, especially when compared to brands like Cresco Labs, which experienced a significant drop in rank from 10th to 18th, alongside a decrease in sales. Meanwhile, Avexia has shown a positive trajectory, climbing from 23rd to 15th place, with sales surpassing Remedi's in October. Mozey Extracts also presents a competitive challenge, having improved its rank to 12th in September before settling at 16th in October, with sales consistently higher than Remedi's. These dynamics suggest that while Remedi is holding steady, it faces significant competition from brands that are either improving their market positions or maintaining higher sales volumes, indicating a need for strategic adjustments to enhance its competitive edge.
Notable Products
In October 2024, the top-performing product for Remedi was the Indica Rest RSO Dropper (0.5g) in the Concentrates category, maintaining its number one rank for four consecutive months with sales reaching 2890 units. The Indica Relief RSO Syringe (0.5g) also held steady in second place, showing consistent performance across the months. A new entry in the rankings, Blueberry Cookies RSO (1g), debuted at third place, indicating strong consumer interest. The CBD/THC 1:1 Relief Tincture (50mg CBD, 50mg THC, 30ml) improved its position to fourth place from fifth in the previous months, demonstrating growing popularity. Meanwhile, the Indica Rest RSO Syringe (0.5g) dropped from fourth to fifth place, suggesting a slight decline in demand compared to other products.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
